Standout Papers

Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burd... 2017 2026 2020 2023 1.6k
  1. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease (2017)
    Chris Estes, Homie Razavi et al. Hepatology

Citation Impact

Citing Papers

Ferroptosis: molecular mechanisms and health implications
2020 Standout
Non-alcoholic fatty liver disease – A global public health perspective
2018 Standout
Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin
2020 StandoutNobel
Understanding Environmental Contaminants’ Direct Effects on Non-alcoholic Fatty Liver Disease Progression
2019
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
2020 Standout
Burden of liver diseases in the world
2018 Standout
The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics
2020 Standout
Hepatocellular carcinoma
2021 Standout
Mechanisms and disease consequences of nonalcoholic fatty liver disease
2021
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Epigenetic Regulation of Kupffer Cell Function in Health and Disease
2021
Non-alcoholic fatty liver disease
2021 Standout
Oophorectomy and risk of non-alcoholic fatty liver disease and primary liver cancer in the Clinical Practice Research Datalink
2019
Global burden of liver disease: 2023 update
2023 Standout
Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study
2018
Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020
2021 Standout
Gut microbiome–targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression
2019
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Hepatocellular carcinoma
2022 Standout
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
2005 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Glycoproteomics
2022 StandoutNobel
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
2018 Standout
A Panel of Glycopeptides as Candidate Biomarkers for Early Diagnosis of NASH Hepatocellular Carcinoma Using a Stepped HCD Method and PRM Evaluation
2021
Burden of Illness and Economic Model for Patients With Nonalcoholic Steatohepatitis in the United States
2018
Healthcare Cost and Utilization in Nonalcoholic Fatty Liver Disease: Real‐World Data From a Large U.S. Claims Database
2018
Patient‐Reported Outcomes and the Economic Effects of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: The Value Proposition
2018
Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research
2020 Standout
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
2023 Standout
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
2020
Therapeutic Potential of Quercetin: New Insights and Perspectives for Human Health
2020 Standout
Nonalcoholic Steatohepatitis
2020
Targeting ferroptosis alleviates methionine‐choline deficient (MCD)‐diet induced NASH by suppressing liver lipotoxicity
2020
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel

Works of Chris Estes being referenced

Epidemiology, Natural History, and Outcomes of Primary Sclerosing Cholangitis: A Systematic Review of Population-based Studies
2021
Modelling NAFLD disease burden in four Asian regions—2019‐2030
2020
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
2017 Standout
Rankless by CCL
2026